Keith A. Goldan, Chief Financial Officer at Syndax Pharmaceuticals Inc (SNDX), sold 1,296 shares at $9.29 ($12K) on 2025-07-16, disclosed to the SEC on 2025-07-18.
Open-market sale of $12k SNDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SNDX | SELL | 2026-02-06 | $43K | — | Filing → |
| SNDX | SELL | 2025-02-12 | $117K | — | Filing → |
| SNDX | BUY | 2024-06-17 | $25K | — | Filing → |